Insights

Growing Market Presence Epistem Ltd. has collaborated with over 200 pharmaceutical and biotech companies, demonstrating a strong track record in supporting drug discovery and development. This expanding network suggests ongoing demand for their specialized preclinical, biomarker, and genetic testing services.

Innovative Technology Use The company's adoption of low-input genetic techniques and pioneering methods such as microdissected material analysis positions it as a leader in advanced biomarker research, providing opportunities to introduce complementary technologies or services that enhance these innovative approaches.

Clinical Development Focus Epistem’s involvement across both preclinical and clinical phases indicates potential for selling integrated solutions, such as new assay platforms or data analysis services, to support seamless progression from laboratory research to clinical trials.

Expansion through Leadership Recent hires of experienced business development and commercial directors highlight a strategic focus on growth, presenting an opening for partners offering scalable commercial tools, global outreach capabilities, or targeted marketing initiatives to accelerate market reach.

Financial Growth Opportunities With current revenue estimates between one and ten million dollars and recent funding of 3.6 million dollars, there is room for expanding advanced research services or integrating new technologies, making it a prime opportunity for customized solutions aimed at tier-one clients seeking innovation.

Epistem Ltd. Tech Stack

Epistem Ltd. uses 8 technology products and services including LinkedIn Ads, Google Ads, Site Kit, and more. Explore Epistem Ltd.'s tech stack below.

  • LinkedIn Ads
    Advertising
  • Google Ads
    Advertising
  • Site Kit
    Analytics
  • Matomo
    Analytics
  • Google Ads Conversion Tracking
    Analytics
  • styled-components
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Swiper
    Javascript Libraries

Epistem Ltd.'s Email Address Formats

Epistem Ltd. uses at least 1 format(s):
Epistem Ltd. Email FormatsExamplePercentage
F.Last@epistem.co.ukJ.Doe@epistem.co.uk
49%
FirstLast@epistem.co.ukJohnDoe@epistem.co.uk
1%
F.Last@epistem.co.ukJ.Doe@epistem.co.uk
49%
FirstLast@epistem.co.ukJohnDoe@epistem.co.uk
1%

Frequently Asked Questions

What is Epistem Ltd.'s phone number?

Minus sign iconPlus sign icon
You can contact Epistem Ltd.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Epistem Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
Epistem Ltd.'s official website is epistem.co.uk and has social profiles on LinkedInCrunchbase.

What is Epistem Ltd.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Epistem Ltd.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Epistem Ltd. have currently?

Minus sign iconPlus sign icon
As of December 2025, Epistem Ltd. has approximately 43 employees across 2 continents, including EuropeAsia. Key team members include Bd Director: A. B.Business Development Manager: J. M.Business Development Manager: L. S.. Explore Epistem Ltd.'s employee directory with LeadIQ.

What industry does Epistem Ltd. belong to?

Minus sign iconPlus sign icon
Epistem Ltd. operates in the Biotechnology Research industry.

What technology does Epistem Ltd. use?

Minus sign iconPlus sign icon
Epistem Ltd.'s tech stack includes LinkedIn AdsGoogle AdsSite KitMatomoGoogle Ads Conversion Trackingstyled-componentsjQuery MigrateSwiper.

What is Epistem Ltd.'s email format?

Minus sign iconPlus sign icon
Epistem Ltd.'s email format typically follows the pattern of F.Last@epistem.co.uk. Find more Epistem Ltd. email formats with LeadIQ.

How much funding has Epistem Ltd. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Epistem Ltd. has raised $3.6M in funding. The last funding round occurred on Jun 07, 2016 for $3.6M.

When was Epistem Ltd. founded?

Minus sign iconPlus sign icon
Epistem Ltd. was founded in 2000.

Epistem Ltd.

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Epistem Ltd. is a leading contract service provider offering innovative preclinical research services, genetic and protein biomarker testing as well as histology services to pharmaceutical, biotech and academic customers to support to drug discovery and development pipelines.  
We have worked with over 200 pharmaceutical and biotechnology companies at both preclinical and clinical stages.  Our high level of expertise and customer focus has led to an enviable track record and impressive amount of repeat business. 
Our preclinical contract research services group advance drug development programs for oncology, inflammatory, dermatology, auto-immune and GI disease indications. We offer an impressive range of preclinical models in these therapeutic areas.  We also provide information relating to toxicity assessments and are experts in GI tox.  We also offer a broad range of cell based assays including novel stem cell assays.
Our biomarker services division offers GCLP compliant genetic testing, histology, FACS analysis and protein biomarker detection. 
Epistem’s genetics group offer gene expression and DNA genotyping sample analysis by NGS, microarray and qPCR.  We specialise in working with small starting materials (down to a single cell input) applying our proprietary low input techniques and products to support drug development programs.  We are specialists in fractionating cell populations and conducting genetic analysis.  We have pioneered techniques using plucked scalp hair and laser capture microdissected material to provide gene expression biomarker information to drug development programs.  
Epistem is committed to provide reliable and innovative services to support all phases of drug development from to preclinical projects to clinical trials.
Website: www.epsitem.co.uk

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
11-50

Section iconFunding & Financials

  • $3.6M

    Epistem Ltd. has raised a total of $3.6M of funding over 1 rounds. Their latest funding round was raised on Jun 07, 2016 in the amount of $3.6M.

  • $1M$10M

    Epistem Ltd.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3.6M

    Epistem Ltd. has raised a total of $3.6M of funding over 1 rounds. Their latest funding round was raised on Jun 07, 2016 in the amount of $3.6M.

  • $1M$10M

    Epistem Ltd.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.